These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12769618)

  • 1. The roles of metabotropic glutamate receptors in seizures and epilepsy.
    Doherty J; Dingledine R
    Curr Drug Targets CNS Neurol Disord; 2002 Jun; 1(3):251-60. PubMed ID: 12769618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.
    Alexander GM; Godwin DW
    Epilepsy Res; 2006 Sep; 71(1):1-22. PubMed ID: 16787741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs.
    Tang FR; Bradford HF; Ling EA
    Curr Med Chem; 2009; 16(17):2189-204. PubMed ID: 19519386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptors and epilepsy.
    Ure J; Baudry M; Perassolo M
    J Neurol Sci; 2006 Aug; 247(1):1-9. PubMed ID: 16697014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate metabotropic receptors as targets for drug therapy in epilepsy.
    Moldrich RX; Chapman AG; De Sarro G; Meldrum BS
    Eur J Pharmacol; 2003 Aug; 476(1-2):3-16. PubMed ID: 12969743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of neuronal excitability and epileptic activities by group II metabotropic glutamate receptors in the medial entorhinal cortex.
    Zhang H; Cilz NI; Yang C; Hu B; Dong H; Lei S
    Hippocampus; 2015 Nov; 25(11):1299-313. PubMed ID: 25740117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status.
    Celli R; Santolini I; Van Luijtelaar G; Ngomba RT; Bruno V; Nicoletti F
    Expert Opin Ther Targets; 2019 Apr; 23(4):341-351. PubMed ID: 30801204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists.
    Folbergrová J; Haugvicová R; Mares P
    Brain Res; 2001 Jul; 908(2):120-9. PubMed ID: 11454322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications.
    Huang L; Xiao W; Wang Y; Li J; Gong J; Tu E; Long L; Xiao B; Yan X; Wan L
    Neural Regen Res; 2024 Feb; 19(2):360-368. PubMed ID: 37488891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
    Barker-Haliski M; White HS
    Cold Spring Harb Perspect Med; 2015 Jun; 5(8):a022863. PubMed ID: 26101204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expressions of glutamate transporters and metabotropic glutamate receptor 1 in the spontaneously epileptic rat hippocampus.
    Guo F; Sun F; Yu JL; Wang QH; Tu DY; Mao XY; Liu R; Wu KC; Xie N; Hao LY; Cai JQ
    Brain Res Bull; 2010 Mar; 81(4-5):510-6. PubMed ID: 19853022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Chronic Pain by Metabotropic Glutamate Receptors.
    Chiechio S
    Adv Pharmacol; 2016; 75():63-89. PubMed ID: 26920009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models in research of pharmacoresistant epilepsy: present and future in development of antiepileptic drugs.
    Kovács R; Heinemann U
    Curr Med Chem; 2014; 21(6):689-703. PubMed ID: 24251565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group I metabotropic glutamate receptors: implications for brain diseases.
    Bordi F; Ugolini A
    Prog Neurobiol; 1999 Sep; 59(1):55-79. PubMed ID: 10416961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of metabotropic glutamate receptors I and III in mouse strains with different susceptibility to experimental temporal lobe epilepsy.
    Chen J; Larionov S; Pitsch J; Hoerold N; Ullmann C; Elger CE; Schramm J; Becker AJ
    Neurosci Lett; 2005 Mar; 375(3):192-7. PubMed ID: 15694259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.
    Lange F; Hörnschemeyer J; Kirschstein T
    Cells; 2021 May; 10(5):. PubMed ID: 34067762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of metabotropic glutamate receptors in epilepsy.
    Wong RK; Bianchi R; Taylor GW; Merlin LR
    Adv Neurol; 1999; 79():685-98. PubMed ID: 10514855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptors as drug targets.
    Récasens M; Guiramand J; Aimar R; Abdulkarim A; Barbanel G
    Curr Drug Targets; 2007 May; 8(5):651-81. PubMed ID: 17504108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia.
    Aronica E; Gorter JA; Jansen GH; van Veelen CW; van Rijen PC; Ramkema M; Troost D
    Epilepsia; 2003 Jun; 44(6):785-95. PubMed ID: 12790891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.